These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10933697)

  • 21. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
    Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE; Schnell MJ; Buonocore L; Rose JK
    J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.
    Stillman EA; Rose JK; Whitt MA
    J Virol; 1995 May; 69(5):2946-53. PubMed ID: 7707520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.
    Wertz GW; Perepelitsa VP; Ball LA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3501-6. PubMed ID: 9520395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generating vesicular stomatitis virus pseudotype bearing the severe acute respiratory syndrome coronavirus spike envelope glycoprotein for rapid and safe neutralization test or cell-entry assay.
    Ge J; Wen Z; Wang X; Hu S; Liu Y; Kong X; Chen H; Bu Z
    Ann N Y Acad Sci; 2006 Oct; 1081(1):246-8. PubMed ID: 17135519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
    Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
    Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors.
    Fang X; Zhang S; Sun X; Li J; Sun T
    Vaccine; 2012 Feb; 30(7):1313-21. PubMed ID: 22222871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligomerization of the Vesicular Stomatitis Virus Phosphoprotein Is Dispensable for mRNA Synthesis but Facilitates RNA Replication.
    Bloyet LM; Morin B; Brusic V; Gardner E; Ross RA; Vadakkan T; Kirchhausen T; Whelan SPJ
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice.
    Stubbs SH; Cornejo Pontelli M; Mishra N; Zhou C; de Paula Souza J; Mendes Viana RM; Lipkin WI; Knipe DM; Arruda E; Whelan SPJ
    mBio; 2021 Aug; 12(4):e0046321. PubMed ID: 34340542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein.
    Oomens AG; Megaw AG; Wertz GW
    J Virol; 2003 Mar; 77(6):3785-98. PubMed ID: 12610153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.
    Meier E; Harmison GG; Schubert M
    J Virol; 1987 Oct; 61(10):3133-42. PubMed ID: 3041035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions.
    Krempl C; Murphy BR; Collins PL
    J Virol; 2002 Dec; 76(23):11931-42. PubMed ID: 12414935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of additional genes in a vector derived from a minimal RNA virus.
    Rolls MM; Haglund K; Rose JK
    Virology; 1996 Apr; 218(2):406-11. PubMed ID: 8610469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
    J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats.
    Xue X; Yu Z; Jin H; Liang L; Li J; Li X; Wang Y; Cui S; Li G
    BMC Vet Res; 2021 Jan; 17(1):36. PubMed ID: 33461549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
    Ory DS; Neugeboren BA; Mulligan RC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
    Kapadia SU; Simon ID; Rose JK
    Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
    Lefkowitz EJ; Pattnaik AK; Ball LA
    Virology; 1990 Oct; 178(2):373-83. PubMed ID: 2171187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.
    Stillman EA; Whitt MA
    J Virol; 1997 Mar; 71(3):2127-37. PubMed ID: 9032346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.